Pharmaceutical Industry

Is the
current model fit for purpose?

These are symptoms of a decline of the pre-digital era model of medicinal product development. Our pharmaceutical industry members are those who are committed to moderninsing their product development to create safer and more effective medicinal products. 

Modernisation of the pharmaceutical industry requires a coresponding moderninsation of the way in which medicinal products are brought on to the market and the design of clinical trials. The Avicenna Alliance is working to promote modelling and simulation as a means of addressing the high cost of research and the uptake of in silico methods.

Avicenna Alliance news

Dassault Systèmes signs Research Agreement with the FDA

Dassault Systèmes and the U.S. Food and Drug Administration have concluded a five-year extension of their collaboration on the 3DEXPERIENCE...

find out more ›

European Commission launches tender for studies on AI and E-Health

On 7 August, the European Commission launched a tender for two studies to survey and analyse progress on the digital transformation...

find out more ›

Commission launches call for proposals to develop AI Excellence Centres

On 12 July, the European Commission has launched a call for proposals to develop a European network of artificial intelligence...

find out more ›

Show all activites